Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY.

Yilin ZhaoYumin MaTianhao BaXueyao HanQian Ren Xiantong Zou

Published in: Diabetes care (2024)

Dorzagliatin was effective and safe in this patient with GCK-MODY, providing potential application prospects for precise treatment of GCK-MODY with dorzagliatin.

Keyphrases

case report
current status
risk assessment
climate change
human health
smoking cessation